Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2019

01-08-2019 | Hepatitis | Case Report

Asymptomatic giant cell hepatitis: a subtype of post-infantile giant cell hepatitis?

Authors: Takahiro Zenda, Ichiro Araki, Motoko Sasaki

Published in: Clinical Journal of Gastroenterology | Issue 4/2019

Login to get access

Abstract

Giant cell hepatitis in adults is considered a rapidly progressive and life-threatening disease, but there are few descriptions of a prolonged disease course. A 36-year-old Japanese man was referred to our hospital for further evaluation of abnormal liver function test results. Although asymptomatic, he had undergone follow-up for 9 years with these abnormalities. Because the cause of liver injury was not identified despite extensive noninvasive examinations, the patient underwent needle biopsy. He was finally diagnosed with post-infantile giant cell hepatitis (PIGCH) based on the presence of small numbers of giant multinucleated hepatocytes scattered primarily around the portal area. Necroinflammatory changes were very mild in the portal tracts and hepatic parenchyma. According to the histological findings as well as the accepted international diagnostic scoring system for autoimmune hepatitis (AIH), which is closely related to PIGCH, AIH was unlikely, although antinuclear antibody was positive at a titer of 1:160. The present case may describe an unknown subtype of PIGCH, characterized by insidious disease onset and progression with concurrent, mildly active underlying hepatitis, which is in contrast with the well-documented aggressive nature of PIGCH.
Literature
1.
go back to reference Johnson SJ, Mathew J, MacSween RN, et al. Post-infantile giant cell hepatitis: histological and immunohistochemical study. J Clin Pathol. 1994;47:1022–7.CrossRefPubMedPubMedCentral Johnson SJ, Mathew J, MacSween RN, et al. Post-infantile giant cell hepatitis: histological and immunohistochemical study. J Clin Pathol. 1994;47:1022–7.CrossRefPubMedPubMedCentral
2.
go back to reference Koskinas J, Deutsch M, Papaioannou C, et al. Post-infantile giant cell hepatitis associated with autoimmune hepatitis and polyarteritis nodosa. Scand J Gastroenterol. 2002;37:120–3.CrossRefPubMed Koskinas J, Deutsch M, Papaioannou C, et al. Post-infantile giant cell hepatitis associated with autoimmune hepatitis and polyarteritis nodosa. Scand J Gastroenterol. 2002;37:120–3.CrossRefPubMed
3.
go back to reference Ishikawa T. Diagnosis and treatment strategy for syncytial giant cell hepatitis. Intern Med. 2012;51:2075–6.CrossRefPubMed Ishikawa T. Diagnosis and treatment strategy for syncytial giant cell hepatitis. Intern Med. 2012;51:2075–6.CrossRefPubMed
4.
go back to reference Labowitz J, Finklestein S, Rabinovitz M. Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature. Am J Gastroenterol. 2001;96:1274–7.CrossRefPubMed Labowitz J, Finklestein S, Rabinovitz M. Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature. Am J Gastroenterol. 2001;96:1274–7.CrossRefPubMed
6.
go back to reference Rabinovitz M, Demetris AJ. Postinfantile giant cell hepatitis associated with anti-M2 mitochondrial antibodies. Gastroenterology. 1994;107:1162–4.CrossRefPubMed Rabinovitz M, Demetris AJ. Postinfantile giant cell hepatitis associated with anti-M2 mitochondrial antibodies. Gastroenterology. 1994;107:1162–4.CrossRefPubMed
8.
11.
go back to reference Lau JY, Koukoulis G, Mieli-Vergani G, et al. Syncytial giant-cell hepatitis—a specific disease entity? J Hepatol. 1992;15:216–9.CrossRefPubMed Lau JY, Koukoulis G, Mieli-Vergani G, et al. Syncytial giant-cell hepatitis—a specific disease entity? J Hepatol. 1992;15:216–9.CrossRefPubMed
12.
go back to reference Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell transformation in hepatitis. Hepatology. 1992;16:327–33.CrossRefPubMed Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell transformation in hepatitis. Hepatology. 1992;16:327–33.CrossRefPubMed
13.
go back to reference Phillips MJ, Blendis LM, Poucell S, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991;324:455–60.CrossRefPubMed Phillips MJ, Blendis LM, Poucell S, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991;324:455–60.CrossRefPubMed
14.
go back to reference Fang JW, González-Peralta RP, Chong SK, et al. Hepatic expression of cell proliferation markers and growth factors in giant cell hepatitis: implications for the pathogenetic mechanisms involved. J Pediatr Gastroenterol Nutr. 2011;52:65–72.CrossRefPubMed Fang JW, González-Peralta RP, Chong SK, et al. Hepatic expression of cell proliferation markers and growth factors in giant cell hepatitis: implications for the pathogenetic mechanisms involved. J Pediatr Gastroenterol Nutr. 2011;52:65–72.CrossRefPubMed
15.
go back to reference Tajiri K, Shimizu Y, Tokimitsu Y, et al. An elderly man with syncytial giant cell hepatitis successfully treated by immunosuppressants. Intern Med. 2012;51:2141–4.CrossRefPubMed Tajiri K, Shimizu Y, Tokimitsu Y, et al. An elderly man with syncytial giant cell hepatitis successfully treated by immunosuppressants. Intern Med. 2012;51:2141–4.CrossRefPubMed
16.
go back to reference Harmanci Ö, Önal IK, Ersoy O, et al. Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies. Dig Dis Sci. 2007;52:3521–3.CrossRefPubMed Harmanci Ö, Önal IK, Ersoy O, et al. Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies. Dig Dis Sci. 2007;52:3521–3.CrossRefPubMed
17.
go back to reference Lerut JP, Claeys N, Ciccarelli O, et al. Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation. Transpl Int. 1998;11:320–2.CrossRefPubMed Lerut JP, Claeys N, Ciccarelli O, et al. Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation. Transpl Int. 1998;11:320–2.CrossRefPubMed
18.
go back to reference Ben-Ari Z, Broida E, Monselise Y, et al. Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis. Am J Gastroenterol. 2000;95:799–801.CrossRefPubMed Ben-Ari Z, Broida E, Monselise Y, et al. Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis. Am J Gastroenterol. 2000;95:799–801.CrossRefPubMed
19.
go back to reference Welte S, Gagesch M, Weber A, et al. Fulminant liver failure in Wilson’s disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both? Eur J Gastroenterol Hepatol. 2012;24:328–31.CrossRefPubMed Welte S, Gagesch M, Weber A, et al. Fulminant liver failure in Wilson’s disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both? Eur J Gastroenterol Hepatol. 2012;24:328–31.CrossRefPubMed
20.
go back to reference Kuntzen T, Friedrichs N, Fischer HP, et al. Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse drug reaction. Eur J Gastroenterol Hepatol. 2005;17:1131–4.CrossRefPubMed Kuntzen T, Friedrichs N, Fischer HP, et al. Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse drug reaction. Eur J Gastroenterol Hepatol. 2005;17:1131–4.CrossRefPubMed
21.
go back to reference Ahmed K, Zucker SD. Giant cell hepatitis in a teenage woman. Clin Gastroenterol Hepatol. 2008;6:A26–A26.e1.CrossRef Ahmed K, Zucker SD. Giant cell hepatitis in a teenage woman. Clin Gastroenterol Hepatol. 2008;6:A26–A26.e1.CrossRef
22.
go back to reference Hayashi H, Narita R, Hiura M, et al. A case of adult autoimmune hepatitis with histological features of giant cell hepatitis. Intern Med. 2011;50:315–9.CrossRefPubMed Hayashi H, Narita R, Hiura M, et al. A case of adult autoimmune hepatitis with histological features of giant cell hepatitis. Intern Med. 2011;50:315–9.CrossRefPubMed
24.
go back to reference Singh V, Rudraraju M, Carey EJ, et al. An unusual occurrence of giant cell hepatitis. Liver Transpl. 2009;15:1888–90.CrossRefPubMed Singh V, Rudraraju M, Carey EJ, et al. An unusual occurrence of giant cell hepatitis. Liver Transpl. 2009;15:1888–90.CrossRefPubMed
25.
go back to reference Moreno-Otero R, Trapero-Marugán M, García-Buey L, et al. Drug-induced postinfantile giant cell hepatitis. Hepatology. 2010;52:2245–6.CrossRefPubMed Moreno-Otero R, Trapero-Marugán M, García-Buey L, et al. Drug-induced postinfantile giant cell hepatitis. Hepatology. 2010;52:2245–6.CrossRefPubMed
26.
go back to reference Torizuka K, Ha-Kawa SK, Kudo M, et al. Phase III multi-center clinical study on 99mTc-GSA, a new agent for functional imaging of the liver (in Japanese, abstract in English). Kaku Igaku. 1992;29:159–81.PubMed Torizuka K, Ha-Kawa SK, Kudo M, et al. Phase III multi-center clinical study on 99mTc-GSA, a new agent for functional imaging of the liver (in Japanese, abstract in English). Kaku Igaku. 1992;29:159–81.PubMed
27.
go back to reference Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed
28.
go back to reference Ikegami T, Matsuzaki Y. Ursodeoxycholic acid: Mechanism of action and novel clinical applications. Hepatol Res. 2008;38:123–31. Ikegami T, Matsuzaki Y. Ursodeoxycholic acid: Mechanism of action and novel clinical applications. Hepatol Res. 2008;38:123–31.
29.
go back to reference Harrison RA, Bahar A, Payne MM. Postinfantile giant cell hepatitis associated with long-term elevated transaminase levels in treated Graves’ disease. Am J Med. 2002;112:326–7.CrossRefPubMed Harrison RA, Bahar A, Payne MM. Postinfantile giant cell hepatitis associated with long-term elevated transaminase levels in treated Graves’ disease. Am J Med. 2002;112:326–7.CrossRefPubMed
30.
go back to reference Stoffel MP, Steffen HM, Dries V, et al. Acute exacerbation of overlapping autoimmune liver disease with development of giant cell hepatitis after 14 years’ disease duration. J Intern Med. 1998;244:355–60.CrossRefPubMed Stoffel MP, Steffen HM, Dries V, et al. Acute exacerbation of overlapping autoimmune liver disease with development of giant cell hepatitis after 14 years’ disease duration. J Intern Med. 1998;244:355–60.CrossRefPubMed
Metadata
Title
Asymptomatic giant cell hepatitis: a subtype of post-infantile giant cell hepatitis?
Authors
Takahiro Zenda
Ichiro Araki
Motoko Sasaki
Publication date
01-08-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00950-6

Other articles of this Issue 4/2019

Clinical Journal of Gastroenterology 4/2019 Go to the issue